Cambridge, MA – January 7th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Glenn Block to its Business Development team.
Glenn Block joins the company as the Executive Director, Sales & Marketing and brings 20+ years’ commercial experience in the neurology & movement disorder space, as well as quality relationships with top KOL neurologists across USA, Canada and Europe and with patient advocacy groups. Glenn’s strong experience and award-winning excellence in leading sales and marketing teams and working with R&D to determine clinical development strategy will bring added value to our clients.
Glenn’s experience as President & GM of a leading biotech company brings an unprecedented level of perspective and insight to both our sales and clinical teams. His ability to grow a sales team, combined with his neurology expertise, makes him an exceptional fit for Stiris”, said Shantal Feltham, President and CEO of Stiris Research. “Glenn brings the strategic leadership and the expertise with launching products, optimizing commercial strategy and product launch that rounds out Stiris’ offering to better support and provide value to our clients.”
Glenn holds a Bachelor of Commerce, Honours degree from Queens University, and was inducted into the Canadian Pharmaceutical Marketing Hall of Fame in 2012.
About Stiris Research
Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.